Frontlight ResearchEarly access
Dilated cardiomyopathy trials in China
5 of 13 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleSafety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 43
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06902896 - Phase 1Taking peopleSafety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
- Where
- Hangzhou
- Age
- 18 years to 75 years
- People
- 5
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07516288 - No phaseTaking peopleProtein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)
- Where
- Wuhan
- Age
- 18 years to 75 years
- People
- 60
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06922851 - No phaseNot yet taking people in ChinaEarly Identification and Treatment of Rare Cardiomyopathy Cohorts
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 300
- Run by
- RenJi Hospital
See details and how to joinNCT06794710 - Phase 4Taking peopleThe Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
- Where
- Wuhan
- Age
- 18 years to 70 years
- People
- 276
- Run by
- Tongji Hospital
See details and how to joinNCT06236022